These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4725954)

  • 1. Fasting serum lipids and serum lipoprotein distribution during oral contraceptive therapy in Nigerians.
    Kuku SB; Akinyanju PA
    J Obstet Gynaecol Br Commonw; 1973 Aug; 80(8):750-3. PubMed ID: 4725954
    [No Abstract]   [Full Text] [Related]  

  • 2. Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
    Lipson A; Stoy DB; LaRosa JC; Muesing RA; Cleary PA; Miller VT; Gilbert PR; Stadel B
    Contraception; 1986 Aug; 34(2):121-34. PubMed ID: 3096633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in plasma lipids caused by oral contraceptives].
    Kaffarnik H
    Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:67-72. PubMed ID: 4114609
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins.
    Wynn V; Niththyananthan R
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):766-71. PubMed ID: 6801982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of oral contraceptive steroids on serum lipids.
    De Alvarez RR; Jahed FM; Spitalny KJ; Elkin H; Jaunakais I
    Am J Obstet Gynecol; 1973 Jul; 116(5):727-49. PubMed ID: 4351501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized comparative open study of the effects of two oral contraceptives, Triphasil and Ortho 7/7/7, on lipid metabolism.
    Kakis G; Powell M; Marshall A; Steiner G
    Contraception; 1993 Feb; 47(2):131-48. PubMed ID: 8449014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen.
    Nash AL; Cornish EJ; Hain R
    Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipids and lipoproteins during treatment with oral contraceptives containing natural and synthetic oestrogens. A controlled double-blind investigation.
    Bostofte E; Hemmingsen L; Møller KJ; Serup J; Weber T
    Acta Endocrinol (Copenh); 1978 Apr; 87(4):855-64. PubMed ID: 347855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of kind of carbohydrate in the diet and use of oral contraceptives on metabolism of young women. II. Serum lipid levels.
    Behall KM; Moser PB; Kelsay JL; Prather ES
    Am J Clin Nutr; 1980 Apr; 33(4):825-31. PubMed ID: 7361701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lipids during oral contraceptive exposure.
    Corredor DG; Mendelsohn LV; Sabeh G; Sunder JH; Danowski TS
    Clin Pharmacol Ther; 1970; 11(2):188-93. PubMed ID: 5416850
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum-lipids in women on oral contraceptives.
    Stokes T; Wynn V
    Lancet; 1971 Sep; 2(7726):677-80. PubMed ID: 4105711
    [No Abstract]   [Full Text] [Related]  

  • 16. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives.
    Oyelola OO
    Contraception; 1993 May; 47(5):445-54. PubMed ID: 8513671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of two low-dose oral contraceptives on serum lipids and lipoproteins: differential changes in high-density lipoprotein subclasses.
    Krauss RM; Roy S; Mishell DR; Casagrande J; Pike MC
    Am J Obstet Gynecol; 1983 Feb; 145(4):446-52. PubMed ID: 6401927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestagens, anabolic-androgenic compounds, estrogens: effects on triglycerides and postheparin lipolytic enzymes.
    Glueck CJ; Scheel D; Fishback J; Steiner P
    Lipids; 1972 Feb; 7(2):110-3. PubMed ID: 4551949
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral contraceptive estrogen and plasma lipid levels.
    Hedlin A; Kuksis A; Geher K
    Obstet Gynecol; 1978 Oct; 52(4):430-5. PubMed ID: 714324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid and lipoprotein changes in women taking low-dose, triphasic oral contraceptives: a controlled, comparative, 12-month clinical trial.
    Notelovitz M; Feldman EB; Gillespy M; Gudat J
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1269-80. PubMed ID: 2655452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.